Authors: Astrid Slagter1, Marieke Vollebergh2, Irene Caspers3,4, Johanna van Sandick5, Karolina Sikorska6, Pehr Lind7,8, Marianne Nordsmark9, Hein Putter10, Jeffrey Braak11, Elma Meershoek-Klein Kranenbarg11, Cornelis van de Velde12, Edwin Jansen1, Annemieke Cats3, Hanneke van Laarhoven13, Nicole van Grieken4, Marcel Verheij1,14
1Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands; 2Netherlands Cancer Institute, Medical Oncology, Amsterdam, The Netherlands; 3Netherlands Cancer Institute, Gastrointestinal Oncology, Amsterdam, The Netherlands; 4Amsterdam University Medical Centers, Pathology, Amsterdam, The Netherlands; 5Netherlands Cancer Institute, Surgery, Amsterdam, The Netherlands; 6Netherlands Cancer Institute, Biometrics, Amsterdam, The Netherlands; 7Stockholm Söder Hospital, Oncology, Stockholm, Sweden; 8Karolinska Institutet, Oncology, Stockholm, Sweden; 9Aarhus University, Medical Oncology, Aarhus, Denmark; 10Leiden University Medical Center, Biometrics, Leiden, The Netherlands; 11Leiden University Medical Center, Surgery, Leiden, The Netherlands; 12Surgery, Leiden University Medical Center, Leiden, The Netherlands; 13Amsterdam University Medical Centers, Medical Oncology, Amsterdam, The Netherlands; 14Radboud University Medical Center, Radiation Oncology, Nijmegen, The Netherlands
Show Affiliations
Hide Affiliations